Sector revisions GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:13 2026-01-20 EST			5-day change	1st Jan Change
1,795.50 ^GBX	-1.13%		-3.36%	-1.59%

10:13pm	PRESS DIGEST-Financial Times - Jan 21	RE
01-20	S&P 500, Nasdaq slump to one-month lows as Greenland dispute triggers global selloff	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GSK PLC							19
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							19
	ASTRAZENECA PLC							20
	NOVARTIS AG							20
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							21
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	BRISTOL-MYERS SQUIBB COMPANY							23
	VERTEX PHARMACEUTICALS INCORPORATED							25
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	BAYER AG							20
	ALNYLAM PHARMACEUTICALS, INC.							25
	Average							22
	Weighted average by Cap.							24